Phenomenex Inc., a Danaher Company and a global leader in separation science technologies, has introduced the Endrix Long Life LC column, a new liquid chromatography solution engineered for extended column lifetime and consistent performance in demanding analytical workflows.
The Endrix Long Life LC is described by Phenomenex as purpose-built for laboratories seeking to reduce downtime, improve throughput, and increase return on investment without sacrificing chromatographic performance. The product was unveiled at the 74th ASMS Conference on Mass Spectrometry and Allied Topics in San Diego, where Phenomenex specialists are available at booth 802 to discuss application data and best practices with attendees.
Column failure: a recurring operational cost labs are looking to solve
Column degradation is a persistent source of unplanned downtime in analytical laboratories, particularly in settings where sample matrices are complex or method conditions are rigorous. Maintaining HPLC and UHPLC system performance involves a continuous trade-off between analytical ambition and hardware longevity, and columns sit at the center of that trade-off.
Endrix Long Life LC is designed to protect against three specific failure mechanisms that Phenomenex identifies as the most common causes of column deterioration: peak distortion, pressure rise from build-up, and performance drift over time. Addressing these failure modes at the hardware level, rather than through guard columns or frequent replacement schedules, is Phenomenex's stated design philosophy for the product.
"Scientists are under constant pressure to deliver high-quality data while managing increasing sample complexity and tighter timelines," said Eric Lavold, Vice President for Product Management and Strategy at Phenomenex. "Endrix Long Life LC was developed to address these challenges directly by delivering exceptional durability and reliable performance over extended use."
By prioritizing column longevity and consistency from the outset, the product is intended to help laboratories maintain method integrity across longer analytical campaigns, reducing the frequency of interruptions between method development and reproducible results.
Target applications and laboratory settings
Phenomenex positions Endrix Long Life LC as particularly well-suited for three laboratory settings where method reliability is critical and column replacement costs carry significant operational weight:
- Pharmaceutical and clinical laboratories, where validated analytical methods must produce consistent results across large sample sets and regulatory scrutiny is high.
- Forensic and toxicology laboratories, where sample matrices are often complex and method reproducibility directly affects the defensibility of results.
- Environmental and food testing laboratories, where high-volume sample throughput and challenging matrix compositions place continuous mechanical and chemical stress on column hardware.
The product forms part of what Phenomenex describes as the latest advancement in its column hardware technology, though specific details of the hardware design, particle chemistry, and available column dimensions were not disclosed in the launch announcement. Laboratories evaluating Endrix will want to probe those specifications, along with compatibility with existing HPLC and UHPLC systems, before integrating it into regulated workflows.
Company context: Phenomenex within the Danaher ecosystem
Phenomenex is headquartered in Torrance, California, and operates as part of Danaher Corporation's Life Sciences platform. Danaher, a global life sciences and diagnostics innovator with approximately 60,000 associates worldwide, provides Phenomenex with access to the Danaher Business System, a continuous improvement framework the parent company credits with enabling operational excellence and accelerated product development across its portfolio companies.
Phenomenex's existing chromatography column portfolio spans HPLC, UHPLC, GC, and preparative applications, covering a wide range of chemistries and particle platforms including the Kinetex core-shell line, the bioZen biopharmaceutical series, and the Luna family of reversed-phase columns. Endrix Long Life LC represents a distinct positioning within that portfolio, with column hardware durability and extended lifecycle as the primary stated design objectives.
What lab managers should consider
The Endrix launch comes at a time when laboratories are under sustained pressure to maximize instrument and consumable utilization. Selecting chromatography systems and columns that deliver consistent performance over longer operational windows reduces both direct replacement costs and the indirect costs of revalidation and downtime.
Interested in chemistry and materials science?
Whether Endrix delivers meaningfully longer service life than comparable columns from competitors will depend on the specific application, sample matrix, and method conditions. Phenomenex has not yet published comparative lifetime data in this launch announcement, and independent validation will be important for laboratories considering adoption in regulated environments. Analysts in pharmaceutical QC or forensic settings will need to satisfy method qualification requirements before switching from established column platforms, which adds a practical lead time to any adoption decision.
The product is available through Phenomenex's global distribution network. For more information, visit phenomenex.com.
References
Phenomenex Inc. "Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability." PR Newswire, June 1, 2026. https://www.prnewswire.com/news-releases/phenomenex-launches-endrix-long-life-columns-redefining-column-durability-and-method-reliability-302786559.html
Danaher Corporation. "About Danaher." Accessed June 2026. https://www.danaher.com
Phenomenex. "Kinetex Core-Shell Technology." Accessed June 2026. https://www.phenomenex.com/products/kinetex-hplc-column
